Pharming Group NV (PHARM) — Cash Flow-to-Debt Ratio
Pharming Group NV (PHARM) has a Cash Flow-to-Debt Ratio of 0.15x as of September 2025, meaning its operating cash flow of €32.03 Million could theoretically repay 0% of its total liabilities (€209.14 Million) in one year. See PHARM FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Pharming Group NV Cash Flow-to-Debt Ratio (2005–2024)
Historical debt coverage capacity for Pharming Group NV across 20 annual periods. Also explore how fast is Pharming Group NV growing its equity to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Pharming Group NV (2005–2024)
Year-by-year debt coverage analysis for Pharming Group NV. For market capitalisation and broader financial context, see Pharming Group NV (PHARM) total market value.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.01x | €-1.79 Million | €172.72 Million | ▲ +87.9% |
| 2023 | -0.09x | €-19.55 Million | €228.28 Million | ▼ -182.7% |
| 2022 | 0.10x | €22.90 Million | €221.16 Million | ▼ -41.5% |
| 2021 | 0.18x | €36.13 Million | €204.19 Million | ▼ -54.2% |
| 2020 | 0.39x | €90.98 Million | €235.39 Million | ▼ -28.3% |
| 2019 | 0.54x | €74.56 Million | €138.38 Million | ▲ +103.9% |
| 2018 | 0.26x | €46.19 Million | €174.81 Million | ▲ +1.9% |
| 2017 | 0.26x | €45.84 Million | €176.82 Million | ▲ +357.4% |
| 2016 | -0.10x | €-10.52 Million | €104.45 Million | ▲ +79.2% |
| 2015 | -0.49x | €-17.95 Million | €37.00 Million | ▼ -137.9% |
| 2014 | -0.20x | €-6.42 Million | €31.46 Million | ▲ +35.1% |
| 2013 | -0.31x | €-11.45 Million | €36.45 Million | ▲ +25.1% |
| 2012 | -0.42x | €-13.58 Million | €32.40 Million | ▲ +30.9% |
| 2011 | -0.61x | €-20.34 Million | €33.55 Million | ▼ -218.4% |
| 2010 | -0.19x | €-6.89 Million | €36.16 Million | ▲ +57.4% |
| 2009 | -0.45x | €-27.24 Million | €60.99 Million | ▼ -138.7% |
| 2008 | -0.19x | €-14.21 Million | €75.96 Million | ▲ +31.4% |
| 2007 | -0.27x | €-31.69 Million | €116.14 Million | ▲ +59.3% |
| 2006 | -0.67x | €-25.89 Million | €38.59 Million | ▲ +69.5% |
| 2005 | -2.20x | €-15.26 Million | €6.93 Million | — |